"As a global leader in particle accelerators, IBA is proud to bring its expertise and advanced technology to this transformative project. Accelerate.EU presents a unique opportunity to push the boundaries of cancer treatment by developing 211At theranostics and accelerating the production and clinical development. With the support of EU funding, we will equip our partners with dedicated state-of-the-art production solutions, offering hope to cancer patients with very limited treatment options. We are proud that our market leading technology is playing such an integral part in addressing the global demand for radiopharmaceuticals."said Charles Kumps, President at IBA RadioPharma Solutions.
About Accelerate.EU
The goal of Accelerate.EU is to establish a stable and reliable cross-European supply chain for 211 At, ensuring broader availability and access to this promising treatment. The project also aims to develop a cutting-edge cyclotron and to enable the deployment of a distribution network to produce 211At for hospitals.
As the project progresses, Accelerate.EU will continue to produce comprehensive educational and training content to support the deployment of these innovative solutions, ensuring long-term knowledge dissemination and impact across Europe.
Acceletate.EU is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No [10173001]. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, Europa Bío, MedTech Europe, and Vaccines Europe.
About IBA
IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,000 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.
Back to HCB News
